Medifast (NYSE:MED) Releases FY23 Earnings Guidance
Medifast (NYSE:MED – Get Free Report) issued an update on its FY23 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $8.65-$9.55 for the period, compared to the consensus estimate of $8.53. The company issued revenue guidance of $1.05-$1.07 billion, compared to the consensus revenue estimate of $1.09 billion. Medifast […]
More Stories
Adaptive Biotechnologies Co. (NASDAQ:ADPT) Short Interest Down 8.5% in November
Adaptive Biotechnologies Co. (NASDAQ:ADPT – Get Free Report) saw a significant decline in short interest in November. As of November...
Okta (NASDAQ:OKTA) Shares Gap Up on Analyst Upgrade
Okta, Inc. (NASDAQ:OKTA – Get Free Report) gapped up prior to trading on Wednesday after Scotiabank raised their price target...
Danaos Co. (NYSE:DAC) Short Interest Up 8.1% in November
Danaos Co. (NYSE:DAC – Get Free Report) saw a large increase in short interest during the month of November. As...
Bowhead Specialty (NYSE:BOW) Hits New 52-Week High on Analyst Upgrade
Bowhead Specialty Holdings Inc. (NYSE:BOW – Get Free Report) shares reached a new 52-week high on Wednesday after Keefe, Bruyette...
inSure DeFi Price Up 27.5% Over Last 7 Days (SURE)
inSure DeFi (SURE) traded up 12.4% against the US dollar during the twenty-four hour period ending at 12:00 PM E.T....
CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Sees Significant Increase in Short Interest
CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW – Get Free Report) saw a significant increase in short interest in the month of...